MoneyWorks4Me

Indoco Remedies informs about disclosure

26 Jul 2024 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023, Indoco Remedies has informed that it enclosed in Annexure A the details of the Order received against appeal filed under Section 107 from the Goods and Service Tax (GST) Authority. Based on the advice of its advisors, Company will be filing appropriate response to the said Order within the prescribed timelines.

The above information is a part of company’s filings submitted to BSE.




Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..